Anti-cytokine Autoantibodies in Autoimmune Diseases

Overview

Journal Am J Clin Exp Immunol

Specialty Allergy & Immunology

Date 2013 Jul 26

PMID 23885320

Citations 27

Authors

Giuseppe Cappellano

Elisabetta Orilieri

Abiy D Woldetsadik

Elena Boggio

Maria F Soluri

Cristoforo Comi

Daniele Sblattero

Annalisa Chiocchetti

Umberto Dianzani

Affiliations

Soon will be listed here.

Abstract

An overview of the current literature is showing that autoantibodies (AutoAbs) against cytokines are produced in several pathological conditions, including autoimmune diseases, but can also be detected in healthy individuals. In autoimmune diseases, these AutoAbs may also be prognostic markers, either negative (such as AutoAbs to IL-8 and IL-1α in rheumatoid arthritis) or positive (such as AutoAbs to IL-6 in systemic sclerosis and those to osteopontin in rheumatoid arthritis). They may have neutralizing activity and influence the course of the physiological and pathological immune responses. High levels of AutoAbs against cytokines may even lead to immunodeficiency, such as those to IL-17 in autoimmune polyendocrine syndrome type I or those to IFN-γ in mycobacterial infections. Their role in human therapy may be exploited not only through passive immunization but also through vaccination, which may improve the costs for long lasting treatments of autoimmune diseases. Detection and quantification of these AutoAbs can be profoundly influenced by the technique used and standardization of these methods is needed to increase the value of their analysis.

Citing Articles

Cytokine Signature Unveils Subgroups of Patients With Immune-Mediated Sensory Neuronopathies.

Moritz C, Tholance Y, Borowczyk C, Jospin F, Paul S, Antoine J J Peripher Nerv Syst. 2025; 30(1):e70008.

PMID: 40037793 PMC: 11879705. DOI: 10.1111/jns.70008.

Direct presentation of inflammation-associated self-antigens by thymic innate-like T cells induces elimination of autoreactive CD8 thymocytes.

You Y, Dunst J, Ye K, Sandoz P, Reinhardt A, Sandrock I Nat Immunol. 2024; 25(8):1367-1382.

PMID: 38992254 PMC: 11291280. DOI: 10.1038/s41590-024-01899-6.

Clinical Significance of Uncommon, Non-Clinical, and Novel Autoantibodies.

Shurin M, Wheeler S Immunotargets Ther. 2024; 13:215-234.

PMID: 38686351 PMC: 11057673. DOI: 10.2147/ITT.S450184.

IL-1RA autoantibodies: insights into mechanisms and associated diseases.

Bouayad A Am J Transl Res. 2024; 16(2):374-386.

PMID: 38463591 PMC: 10918145.

Anti-cytokine autoantibodies: mechanistic insights and disease associations.

Cheng A, Holland S Nat Rev Immunol. 2023; 24(3):161-177.

PMID: 37726402 DOI: 10.1038/s41577-023-00933-2.

References

Notarangelo L, Mazza C, Forino C, Mazzolari E, Buzi F . AIRE and immunological tolerance: insights from the study of autoimmune polyendocrinopathy candidiasis and ectodermal dystrophy. Curr Opin Allergy Clin Immunol. 2005; 4(6):491-6. DOI: 10.1097/00130832-200412000-00004. View

DeForge L, Loyet K, DeLarosa D, Chinn J, Zamanian F, Chuntharapai A . Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF. J Immunol Methods. 2010; 362(1-2):70-81. DOI: 10.1016/j.jim.2010.09.004. View

Svenson M, Hansen M, Ross C, Diamant M, Rieneck K, Nielsen H . Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations. Blood. 1998; 91(6):2054-61. View

Meager A, Wadhwa M, Dilger P, Bird C, Thorpe R, Newsom-Davis J . Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis. Clin Exp Immunol. 2003; 132(1):128-36. PMC: 1808678. DOI: 10.1046/j.1365-2249.2003.02113.x. View

Ding L, Mo A, Jutivorakool K, Pancholi M, Holland S, Browne S . Determination of human anticytokine autoantibody profiles using a particle-based approach. J Clin Immunol. 2011; 32(2):238-45. DOI: 10.1007/s10875-011-9621-8. View

de Lemos Rieper C, Galle P, Svenson M, Pedersen B, Hansen M . Preparation and validation of radio iodinated recombinant human IL-10 for the measurement of natural human antibodies against IL-10. J Immunol Methods. 2009; 350(1-2):46-53. DOI: 10.1016/j.jim.2009.07.005. View

Harboe E, Damas J, Omdal R, Froland S, Sjursen H . [Risk of infection through use of selective immunomodulating drugs for rheumatoid arthritis]. Tidsskr Nor Laegeforen. 2012; 132(16):1867-71. DOI: 10.4045/tidsskr.12.0180. View

Ratsimandresy R, Rappaport J, Zagury J . Anti-cytokine therapeutics: history and update. Curr Pharm Des. 2009; 15(17):1998-2025. DOI: 10.2174/138161209788453130. View

Sjowall C, Kastbom A, Almroth G, Wettero J, Skogh T . Beware of antibodies to dietary proteins in "antigen-specific" immunoassays! falsely positive anticytokine antibody tests due to reactivity with bovine serum albumin in rheumatoid arthritis (the Swedish TIRA project). J Rheumatol. 2010; 38(2):215-20. DOI: 10.3899/jrheum.100690. View

10.

Dalum I, Butler D, Jensen M, Hindersson P, Steinaa L, Waterston A . Therapeutic antibodies elicited by immunization against TNF-alpha. Nat Biotechnol. 1999; 17(7):666-9. DOI: 10.1038/10878. View

11.

Firestein G . Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis Rheum. 1996; 39(11):1781-90. DOI: 10.1002/art.1780391103. View

12.

Uyttenhove C, Arendse B, Stroobant V, Brombacher F, Van Snick J . Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection. Eur J Immunol. 2004; 34(12):3572-81. DOI: 10.1002/eji.200425443. View

13.

Meager A, Wadhwa M, Bird C, Dilger P, Thorpe R, Newsom-Davis J . Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease. Immunology. 1999; 97(3):526-32. PMC: 2326850. DOI: 10.1046/j.1365-2567.1999.00806.x. View

14.

Ozen S, Berk O, Simsek D, Darcan S . Clinical course of Hashimoto's thyroiditis and effects of levothyroxine therapy on the clinical course of the disease in children and adolescents. J Clin Res Pediatr Endocrinol. 2011; 3(4):192-7. PMC: 3245492. DOI: 10.4274/jcrpe.425. View

15.

Sakata M, Tsuruha J, Masuko-Hongo K, Nakamura H, Matsui T, Sudo A . Autoantibodies to osteopontin in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol. 2001; 28(7):1492-5. View

16.

Slavikova M, Schmeisser H, Kontsekova E, Mateicka F, Borecky L, Kontsek P . Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia. J Interferon Cytokine Res. 2003; 23(3):143-7. DOI: 10.1089/107999003321532475. View

17.

Hellmich B, Csernok E, Schatz H, Gross W, Schnabel A . Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus. Arthritis Rheum. 2002; 46(9):2384-91. DOI: 10.1002/art.10497. View

18.

Chakraborty A, Tannenbaum S, Rordorf C, Lowe P, Floch D, Gram H . Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1β monoclonal antibody. Clin Pharmacokinet. 2012; 51(6):e1-18. PMC: 3584253. DOI: 10.2165/11599820-000000000-00000. View

19.

Primus F, Kelley E, Hansen H, Goldenberg D . "Sandwich"-type immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy. Clin Chem. 1988; 34(2):261-4. View

20.

Peichl P, Pursch E, Broll H, Lindley I . Anti-IL-8 autoantibodies and complexes in rheumatoid arthritis: polyclonal activation in chronic synovial tissue inflammation. Rheumatol Int. 1999; 18(4):141-5. DOI: 10.1007/s002960050073. View